Treatment of glioblastoma multiforme cells with temozolomide-BioShuttle ligated by the inverse Diels...
Treatment of glioblastoma multiforme cells with temozolomide-BioShuttle ligated by the inverse Diels-Alder ligation chemistry
About this item
Full title
Author / Creator
Publisher
New Zealand: Dove Medical Press
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Dove Medical Press
Subjects
More information
Scope and Contents
Contents
Recurrent glioblastoma multiforme (GBM), insensitive against most therapeutic interventions, has low response and survival rates. Temozolomide (TMZ) was approved for second-line therapy of recurrent anaplastic astrocytoma. However, TMZ therapy in GBM patients reveals properties such as reduced tolerability and inauspicious hemogram. The solution ad...
Alternative Titles
Full title
Treatment of glioblastoma multiforme cells with temozolomide-BioShuttle ligated by the inverse Diels-Alder ligation chemistry
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2761188
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2761188
Other Identifiers
E-ISSN
1177-8881
